The Emerging Role of SGLT2-i in Cardio-Nephroprotection SGLT2 is a low-affinity high-capacity co-transporter distributed mainly along the early segments of the proximal renal tubule
Her reflexes were absent at the knees and 2+ at the biceps, triceps, finger flexors, and ankles
GLP-1/GIP medications do not: reduce central pain amplification correct nervous-system hypersensitivity treat neuropathic pain reverse joint degeneration Some patients feel better simply because weight loss improves sleep, mobility, energy, and moodnot because the medication treats fibromyalgia biology
Alcohol impairs the liver's ability to release glucose into the blood, which can lead to dangerous drops in blood glucose levels and hypoglycemia
Additionally, these therapies can cut cardiovascular risk by 20%, offering metabolic advantages that go hand-in-hand with the weight loss outcomes